Effective January 1, 2019—Changes To Part B Drug Pricing
Medicare Part B covers drugs administered in physician offices and hospital outpatient departments by infusion or injection—such as drugs to treat cancer, macular degeneration, and rheumatoid arthritis. From 2011 to 2016, Medicare Part B drug spending grew from $17.6 billion to $28 billion, representing a compound annual growth rate of 9.8%.
